Safety and Optimal Neuroprotection of neu2000 in Ischemic Stroke With Endovascular reCanalizion (SONIC)

NCT02831088 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

210

Enrollment

INDUSTRY

Sponsor class

Conditions

Ischemic Stroke

Interventions

DRUG: Neu2000KWL High-does group
DRUG: Neu2000KWL Low-does group
DRUG: Placebo

Sponsor

GNT Pharma